Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients
NCT ID: NCT01278693
Last Updated: 2011-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
54 participants
INTERVENTIONAL
2009-08-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Acute Lysine Administration on α-aminoadipic Acid
NCT02756117
Trial of Oral Glutamine on Mitochondrial Function in CKD
NCT02838979
The Efficacy and Safety of an Amino Acid Supplement in Adults
NCT05599282
Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension
NCT02125045
Oral Glutathione Supplementation on the Levels of Blood Glutathione
NCT01044277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
it is as like as L-carnitine in shape
placebo
500 mg,twice daily, 16 weeks.
L-carnitine
it is kind of supplement
L-carnitine
500 mg,twice daily, 16 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-carnitine
500 mg,twice daily, 16 weeks
placebo
500 mg,twice daily, 16 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Isfahan University of Medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahnaz Moradi, MD
Role: STUDY_CHAIR
MD,research comittee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Noor university hospital
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nishioka N, Luo Y, Taniguchi T, Ohnishi T, Kimachi M, Ng RC, Watanabe N. Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD013601. doi: 10.1002/14651858.CD013601.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASD-1213-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.